نتایج جستجو برای: kit

تعداد نتایج: 29127  

Journal: :Blood 1995
K Ogawa Y Takeda M Tashima H Sawai T Toi T Okazaki H Sawada Y Maruyama M Okuma

We previously reported that the K562 cell line K562YO expressed a high level of the c-kit gene. In this study, we analyzed the mechanism of this expression and investigated the effects of the serine/threonine kinases such as protein kinase C (PKC) and cyclic adenosine 3',5'-monophosphate (cAMP)-dependent kinase (PKA) on it. The half-life of the c-kit mRNA in K562YO cells was greater than 10 hou...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
Stefania Uccini Olga Mannarino Heather P McDowell Ursula Pauser Roberta Vitali Pier Giorgio Natali Pierluigi Altavista Tiziana Andreano Simona Coco Renata Boldrini Sandro Bosco Anna Clerico Denis Cozzi Alberto Donfrancesco Alessandro Inserra George Kokai Paul D Losty Maria R Nicotra Giuseppe Raschellà Gian Paolo Tonini Carlo Dominici

PURPOSE Clinicobiological characteristics of neuroblastic tumor (NT) expressing c-kit tyrosine kinase receptor and/or its ligand, stem cell factor (SCF), are debated. This study aimed at investigating the clinicobiological features of primary NTs expressing c-kit and/or SCF in order to define the clinical relevance of selective therapeutic targeting. EXPERIMENTAL DESIGN c-Kit and SCF expressi...

Journal: :Blood 1994
P S Cohen J P Chan M Lipkunskaya J L Biedler R C Seeger

During development, mice with mutations of stem cell factor (SCF) or its receptor c-kit exhibit defects in melanogenesis, as well as hematopoiesis and gonadogenesis. Because melanocytes derive from neural crest cells, the role of SCF and c-kit was investigated in the neural crest-derived childhood tumor neuroblastoma. Using reverse transcription-polymerase chain reaction analysis, simultaneous ...

2003
Michael C. Heinrich

Introduction SCLC represents a significant minority of lung cancer (15–25%) and typically presents as extensive-stage disease. Although SCLC is highly responsive to cisplatin-based combination chemotherapy, most patients have disease recurrence and few patients are cured. A plateau in the development of effective medical therapy for this difficult cancer has led to a search for new active agent...

2013
Nicole L. Podnecky Mindy G. Elrod Bruce R. Newton Leslie A. Dauphin Jianrong Shi Sutthinan Chawalchitiporn Henry C. Baggett Alex R. Hoffmaster Jay E. Gee

Burkholderia pseudomallei, the etiologic agent of melioidosis, is endemic in northern Australia and Southeast Asia and can cause severe septicemia that may lead to death in 20% to 50% of cases. Rapid detection of B. pseudomallei infection is crucial for timely treatment of septic patients. This study evaluated seven commercially available DNA extraction kits to determine the relative recovery o...

Journal: :Cancer research 2008
Keiran S M Smalley Rooha Contractor Thiennga K Nguyen Min Xiao Robin Edwards Viswanathan Muthusamy Alastair J King Keith T Flaherty Marcus Bosenberg Meenhard Herlyn Katherine L Nathanson

Although many melanomas harbor either activating mutations in BRAF or NRAS, there remains a substantial, yet little known, group of tumors without either mutation. Here, we used a genomic strategy to define a novel group of melanoma cell lines with co-overexpression of cyclin-dependent kinase 4 (CDK4) and KIT. Although this subgroup lacked any known KIT mutations, they had high phospho-KIT rece...

Journal: :Blood 2006
Karoline V Gleixner Matthias Mayerhofer Karl J Aichberger Sophia Derdak Karoline Sonneck Alexandra Böhm Alexander Gruze Puchit Samorapoompichit Paul W Manley Doriano Fabbro Winfried F Pickl Christian Sillaber Peter Valent

In most patients with systemic mastocytosis (SM), including aggressive SM and mast cell leukemia (MCL), neoplastic cells express the oncogenic KIT mutation D816V. KIT D816V is associated with constitutive tyrosine kinase (TK) activity and thus represents an attractive drug target. However, imatinib and most other TK inhibitors fail to block the TK activity of KIT D816V. We show that the novel T...

Journal: :Blood 1995
K Miyazawa D A Williams A Gotoh J Nishimaki H E Broxmeyer K Toyama

Alternative splicing of exon 6 results in the production of two isoforms of Steel factor (SLF): the membrane-bound and soluble forms. To investigate differences in the kinetics of c-kit tyrosine kinase activated by these two isoforms, we used a stromal cell line (SI/SI4) established from SI/SI homozygous murine embryo fetal liver and its stable transfectants containing either hSCF248 cDNA (incl...

Journal: :Development 1992
H Maeda A Yamagata S Nishikawa K Yoshinaga S Kobayashi K Nishi

A discovery that the protooncogene encoding the receptor tyrosine kinase, c-kit, is allelic with the Dominant white spotting (W) locus establishes that c-kit plays a functional role in the development of three cell lineages, melanocyte, germ cell, and hematopoietic cell which are defective in W mutant mice. Recent analyses of c-kit expression in various tissues of mouse, however, have demonstra...

Journal: :Blood 1995
C L Li G R Johnson

Murine bone marrow cells were fractionated by fluorescence-activated cell sorting into Rh123lo Lin- c-kit+ Ly6A+, Rh123hi Lin-c-kit+ Ly6A+, and Lin- c-kit+ Ly6A- populations within which most, if not all, of the hematopoietic activities of the marrow resided. The Rh123lo Lin- c-kit+Ly6A+ cells, which consist exclusively of small- or medium-sized lymphocyte-like cells, are highly enriched for lo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید